Acquisition by Ming Yan of 3683 shares of Cytek Biosciences subject to Rule 16b-3

1736 Stock  TWD 150.50  7.00  4.44%   
Slightly above 61% of Johnson Health's investor base is looking to short. The analysis of current outlook of investing in Johnson Health Tech suggests that many traders are alarmed regarding Johnson Health's prospects. Johnson Health's investing sentiment can be driven by a variety of factors including economic data, Johnson Health's earnings reports, geopolitical events, and overall market trends.
Johnson Health stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Johnson daily returns and investor perception about the current price of Johnson Health Tech as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by Cytek Biosciences Director, Officer: Chief Technology Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Cytek insider trading alert for acquisition of common stock by Ming Yan, Director, Officer: Chief Technology Officer, on 22nd of May 2024. This event was filed by Cytek Biosciences with SEC on 2024-05-20. Statement of changes in beneficial ownership - SEC Form 4

Johnson Health Fundamental Analysis

We analyze Johnson Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Johnson Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Johnson Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Retained Earnings

Retained Earnings Comparative Analysis

Johnson Health is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Johnson Health Tech Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Johnson Health stock to make a market-neutral strategy. Peer analysis of Johnson Health could also be used in its relative valuation, which is a method of valuing Johnson Health by comparing valuation metrics with similar companies.

Additional Tools for Johnson Stock Analysis

When running Johnson Health's price analysis, check to measure Johnson Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Johnson Health is operating at the current time. Most of Johnson Health's value examination focuses on studying past and present price action to predict the probability of Johnson Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Johnson Health's price. Additionally, you may evaluate how the addition of Johnson Health to your portfolios can decrease your overall portfolio volatility.